Nemaura Medical has a total of 38 patents globally, out of which 19 have been granted. Of these 38 patents, more than 63% patents are active. The UK is where Nemaura Medical has filed the maximum number of patents, followed by United States of America and Japan, it has generated an annual revenue of $3.53 billion in the year 2021. Parallelly, China seems to be the main focused R&D centre of Nemaura Medical.
Nemaura Medical was founded in the year 2013 by Dr Faz Chowdhury. Nemaura is a UK based Medical Technology Company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT. As of August 2022, Nemaura Medical has a market cap of $50.76 Million.
Do read about some of the most popular patents of Nemaura Medical which have been covered by us in this article and also you can find Nemaura Medical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nemaura Medical patent portfolio.
How many patents does the founder and the CEO of Nemaura Medical have?
The founder & CEO, Dr Faz Chowdhury, has 0 patents.
How many patents does Nemaura Medical have?
Nemaura Medical has a total of 38 patents globally. These patents belong to 14 unique patent families. Out of 38 patents, 24 patents are active.
How Many Patents did Nemaura Medical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Nemaura Medical Applications Filed||Nemaura Medical Patents Granted|
How many Nemaura Medical patents are Alive/Dead?
How Many Patents did Nemaura Medical File in Different Countries?
Countries in which Nemaura Medical Filed Patents
|United States Of America||5|
|United Arab Emirates||1|
|Hong Kong (S.A.R.)||1|
Where are Research Centres of Nemaura Medical Patents Located?
Most Cited Nemaura Medical Patents
US20120323097A9 is the most popular patent in the Nemaura Medical portfolio. It has received 26 citations so far from companies like Zyomed and Biolinq. The invention relates to patches for applying to the skin of a patient, whereby constituents of fluids in the skin for analysis can be withdrawn through the skin by the technique of reverse iontophoresis.
The company created SugarBEAT, a disposable skin patch that adheres to the body using a soft silicone gel that is not irritant. The rechargeable transmitter that the skin patch links to measures blood sugar levels and sends the information to a mobile app every five minutes.
List of Nemaura Medical Patents
|US10092224B2||Cumulative Measurement Of An Analyte|
|US20220054767A1||Skin Preparation Patches|
|US20220023229A1||Attachment Of Membranes For Transdermal Devices|
|US20180197637A1||Consumer Wellbeing Algorithm|
|US20120323097A9||Patch For Reverse Iontophoresis|
|EP2852323B1||Cumulative Measurement Of An Analyte|
|EP3893729A1||Attachment Of Membranes For Transdermal Devices|
|EP3890647A1||Skin Preparation Patches|
|CN104470428B||Cumulative Measurement Of Analyte|
|WO2020120511A1||Attachment Of Membranes For Transdermal Devices|
|WO2020115465A1||Skin Preparation Patches|
|GB2579575B||Skin Preparation Patches|
|GB2579651B||Attachment Of Membranes For Transdermal Devices|
|GB2497726B||Determining The Volume Of A Liquid In A Reverse Iontophoresis Chamber|
|GB2502287B||Cumulative Measurement Of An Analyte|
|GB202117714D0||Davices For Measuring Markers For Metabolic Health|
|GB202003457D0||Pre-Treating Skin For Extracting And Measuring The Concentration Of Substance In A Subject|
|GB201915625D0||Calibration Of Analyte Sensors|
|GB201603668D0||Method For Determining Concentration Of Substances In A Subject|
|GB201508754D0||Method For Determining Concentration Of Substances In A Subject|
|GB201504015D0||Liquid Containing Skin Patches|
|GB201305352D0||Connection Means For Medical Sensor And Device|
|DE602013011114T2||Cumulative Measurement Of An Analyte|
|DE602009007570T2||Pavement For Reverse Iontophoresis|
|PL2852323T3||Cumulative Measurement Of An Analyte|
|ES2614755T3||Cumulative Measurement Of An Analyte|
|JP6538554B2||Cumulative Measurement Of Analytes|
|JP6294850B2||Patch For Reverse Iontophoresis And Method Of Operating The Patch|
|JP5794914B2||Patch For Reverse Ion Tophoresis|
|JP2022518967A||Connectors Of Membranes For Transdermal Devices|
|CA2873616C||Cumulative Measurement Of An Analyte|
|CA2766331A1||Patches For Reverse Iontophoresis|
|AU2013264992B2||Cumulative Measurement Of An Analyte|
|AU2009265416B2||Patches For Reverse Iontophoresis|
|BR112014028850B1||Method Of Monitoring Of An Analyte Level In A Subject|
|AE1273B||Cumulative Measurement Of An Analyte|
|IN2847KOLNP2014A||Cumulative Measurement Of An Analyte|
|HK1156199A1||Patches For Reverse Iontophoresis|
EXCLUSIVE INSIGHTS COMING SOON!
What are Nemaura Medical’s key innovation segments?
What Technologies are Covered by Nemaura Medical?
The chart below distributes patents filed by Nemaura Medical in different countries on the basis of the technology protected in patents. It also represents the markets where Nemaura Medical thinks it’s important to protect particular technology inventions.
R&D Focus: How Nemaura Medical’s search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Nemaura Medical?